EUVIMEDEUVIMED entdecken
Crossref

Medical Costs, Health Care Utilization, and Productivity Losses Associated With Hypertension Moderated by COVID-19 Diagnosis Among US Commercial Enrollees

Jun Soo Lee iD, Yidan Xue Zhang, Yu Wang, Joohyun Park, Ashutosh Kumar, Bruce Donald iD, Feijun Luo, Kakoli Roy

American Journal of Hypertension · 2026

DOI: 10.1093/ajh/hpaf081 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Hypertension, 2026. Verfasst von Jun Soo Lee und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division for Heart Disease and Stroke Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, USA. Hauptthemen laut MEDLINE: COVID-19, Hypertension, Health Care Costs, Patient Acceptance of Health Care. Die Arbeit nennt 45 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND Hypertension is a major risk factor for cardiovascular and renal diseases, significantly contributing to morbidity and mortality. The COVID-19 pandemic has heightened concerns about the impact of hypertension on severe COVID-19 outcomes. METHODS We analyzed 2020–2021 data from the MarketScan Commercial and Health and Productivity Management databases, focusing on adults aged 18–64 years with continuous employer-sponsored private insurance, excluding pregnancy or capitated plans. We compared medical costs, healthcare utilization (emergency department [ED] visits, inpatient admissions, outpatient visits, and outpatient prescription drugs), and productivity losses (sick absences, short-term disability [STD], and long-term disability) between individuals with and without hypertension, stratified by COVID-19 diagnosis. We used multivariable regression models, including an interaction term for hypertension and COVID-19 diagnosis, to estimate differences in outcomes, adjusting for demographics and comorbidities. RESULTS Among 1,296,596 adults, 21% had hypertension. Those with hypertension were older, less likely female, less likely urban residents, and had more comorbidities. Excess medical costs associated with hypertension were $8,572 per patient over the 2-year period (95% CI $8,182–$8,962). Patients with vs. without hypertension had 0.200 (95% CI, 0.195–0.205) more ED visits, 0.081 (95% CI, 0.077–0.085) more inpatient admissions, 5.984 (95% CI, 5.892–6.075) more outpatient visits, and 20.25 (95% CI, 20.09–20.41) more prescriptions per patient over the 2-year period. They also had more sick absences (1.13 days; 95% CI 0.93–1.34) and STD occurrences (3.88 days; 95% CI 3.56–4.20) per patient. Among those with hypertension, individuals with vs. without COVID-19 had $3,495 (95% CI, $2,135–$4,856) higher medical costs and 2.588 (95% CI, 1.112–4.065) more STD days per patient over the 2-year period. CONCLUSIONS Hypertension was associated with higher medical costs, healthcare utilization, and productivity losses, exacerbated by COVID-19.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19HypertensionHealth Care CostsPatient Acceptance of Health CareEfficiencyHumansFemaleAdultMiddle AgedMaleUnited StatesAdolescentYoung AdultSick LeaveSARS-CoV-2AbsenteeismComorbidityHospitalization

Stichwörter der Autor:innen

COVID-19blood pressurecommercial insurancehealth care utilizationhypertensionmedical costsproductivity costsproductivity loss

Autor:innen und Institutionen

  • Division for Heart Disease and Stroke Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • ASRT, Inc., Atlanta, Georgia, USA.
  • Division of Workforce Development, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Data Science and Evaluation Team, American Heart Association, Dallas, Texas, USA.
  • Division of Drug Overdose Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Bizzell US, New Carrollton, Maryland, USA.

ORCID-Profile: Jun Soo Lee, Bruce Donald

Zitieren

APA

Lee, J. S., Zhang, Y. X., Wang, Y., Park, J., Kumar, A., Donald, B., Luo, F., & Roy, K. (2026). Medical Costs, Health Care Utilization, and Productivity Losses Associated With Hypertension Moderated by COVID-19 Diagnosis Among US Commercial Enrollees. American Journal of Hypertension. https://doi.org/10.1093/ajh/hpaf081

Vancouver

Lee JS, Zhang YX, Wang Y, Park J, Kumar A, Donald B, et al. Medical Costs, Health Care Utilization, and Productivity Losses Associated With Hypertension Moderated by COVID-19 Diagnosis Among US Commercial Enrollees. American Journal of Hypertension. 2026. doi:10.1093/ajh/hpaf081

BibTeX
@article{Lee2026,
  author = {Lee, Jun Soo and Zhang, Yidan Xue and Wang, Yu and Park, Joohyun and Kumar, Ashutosh and Donald, Bruce and Luo, Feijun and Roy, Kakoli},
  title = {Medical Costs, Health Care Utilization, and Productivity Losses Associated With Hypertension Moderated by COVID-19 Diagnosis Among US Commercial Enrollees},
  journal = {American Journal of Hypertension},
  year = {2026},
  doi = {10.1093/ajh/hpaf081}
}
Kostenlos starten →